Wave life sciences to present at the h.c. wainwright 25th annual global investment conference

Cambridge, mass., sept. 06, 2023 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage rna medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in a virtual analyst-led fireside chat at the h.c. wainwright 25th annual global investment conference. the presentation will be available to view beginning on monday, september 11, 2023, at 7:00 a.m. et.
WVE Ratings Summary
WVE Quant Ranking